Form 4 for NVAX NOVAVAX INC
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-07 · accession 0001104659-26-025369 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-09 | 2026-03-07 | NVAX | Kelly James Patrick | EVP, CFO, Treas | M - OptEx | $0.00 | +12.2K | 136.5K | +10% | $0 |
| D | 2026-03-09 | 2026-03-07 | NVAX | Kelly James Patrick | EVP, CFO, Treas | F - Tax | $9.98 | -5,904 | 130.6K | -4% | -$58.9K |
| D | 2026-03-09 | 2026-03-07 | NVAX | Kelly James Patrick | EVP, CFO, Treas | M - OptEx | $0.00 | -12.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-07 | M | A | 12,223 | $0.00 | 136,503 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-07 | F | D | 5,904 | $9.98 | 130,599 | D | — | — | (F1) Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting. |
| 3 | Derivative | Restricted Stock Units | 2026-03-07 | M | D | 12,223 | $0.00 | 0 | D | $0.00 · — to 2033-03-07 | 12,223 Common Stock | (F2) One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the March 7, 2023 grant date, in each case subject to continued employment through such vesting date. |